Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway

被引:2
|
作者
Nakanishi, T
Hayashi, A
Kunisawa, J
Tsutsumi, Y
Tanaka, K
Yashiro-Ohtani, Y
Nakanishi, M
Fujiwara, H
Hamaoka, T
Mayumi, T
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Toxicol, Osaka, Japan
[3] Osaka Univ, Sch Med, Biomed Res Ctr, Osaka 553, Japan
[4] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan
关键词
cytotoxic T lymphocyte; MHC class I; fusogenic liposome; vaccine; ovalbumin;
D O I
10.1002/1521-4141(200006)30:6<1740::AID-IMMU1740>3.0.CO;2-U
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Exogenous soluble proteins enter the endosomal pathway by endocytosis and are presented in association with MHC class II rather than class I. In contrast, the delivery of exogenous protein antigens (Ag) into the cytosol generates MHC class I-restricted cytotoxic T lymphocytes (CTL) responses. Although several immunization approaches, such as the utilization of liposomes, have induced the in vivo priming of MHC class I-restricted CTL responses to protein Ag, it remains unclear whether this priming results from the direct delivery of protein Ag to the cytosol. Here we report that fusogenic liposomes (FL), which are prepared by fusing simple liposomes with Sendai virus particles, can deliver the encapsulated soluble protein directly into the cytosol of cells cultured concurrently and introduce it into the conventional MHC class I Ag presentation pathway. Moreover, a single immunization with ovalbumin (OVA) encapsulated in FL but not in simple liposomes results in the potent priming of OVA-specific CTL. Thus, FL function as an efficient tool for the delivery of CTL vaccines.
引用
收藏
页码:1740 / 1747
页数:8
相关论文
共 50 条
  • [1] Recombinant yeast efficiently deliver antigen into the MHC class-I processing pathway of dendritic cells.
    Stubbs, AC
    Martin, KS
    Franzusoff, A
    Bellgrau, D
    Duke, RC
    Wilson, CC
    FASEB JOURNAL, 2000, 14 (06): : A1056 - A1056
  • [2] CHARACTERIZATION OF THE EXOGENOUS ANTIGEN MHC CLASS-I PRESENTATION PATHWAY
    KOVACSOVICSBANKOWSKI, M
    ROCK, KL
    FASEB JOURNAL, 1994, 8 (05): : A991 - A991
  • [3] Protein sampling by the MHC Class I antigen processing pathway
    Hoof, I.
    van Baarle, D.
    Kesmir, C.
    TISSUE ANTIGENS, 2011, 77 (05): : 421 - 422
  • [4] ELECTROPORATION AND COMMERCIAL LIPOSOMES EFFICIENTLY DELIVER SOLUBLE-PROTEIN INTO THE MHC CLASS-I PRESENTATION PATHWAY - PRIMING INVITRO AND INVIVO FOR CLASS I-RESTRICTED RECOGNITION OF SOLUBLE-ANTIGEN
    CHEN, WS
    CARBONE, FR
    MCCLUSKEY, J
    JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 160 (01) : 49 - 57
  • [5] Integrated modeling of the major events in the MHC class I antigen processing pathway
    Dönnes, P
    Kohlbacher, O
    PROTEIN SCIENCE, 2005, 14 (08) : 2132 - 2140
  • [6] MHC class I antigen processing pathways
    Maffei, A
    Papadopoulos, K
    Harris, PE
    HUMAN IMMUNOLOGY, 1997, 54 (02) : 91 - 103
  • [7] The proteasorne and MHC class I antigen processing
    Kloetzel, PM
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2004, 1695 (1-3): : 225 - 233
  • [8] Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I dependent trimming in the ER
    Shastri, N
    Serwold, T
    Paz, P
    Brouwenstijn, N
    FASEB JOURNAL, 2000, 14 (06): : A1196 - A1196
  • [9] Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway
    de Haan, L
    Hearn, AR
    Rivett, AJ
    Hirst, TR
    INFECTION AND IMMUNITY, 2002, 70 (06) : 3249 - 3258
  • [10] Pathways for exogenous antigen presentation by MHC class I molecules
    Shen, L
    Rock, KL
    FASEB JOURNAL, 2000, 14 (06): : A1196 - A1196